iNAP Sleep
Update：2026/07/14
Industries
Main Industry
Health Care
Main Product/Service
iNAP One (iNAP Sleep Apnea Therapy Device):
Used for the treatment of obstructive sleep apnea (OSA) in adults. The system utilizes a soft and flexible mouthpiece, a thin tube, and a smartphone-sized, silent, battery-powered control console to provide gentle oral negative pressure during sleep, comfortably maintaining an open airway while allowing normal breathing through the nose.
Used for the treatment of obstructive sleep apnea (OSA) in adults. The system utilizes a soft and flexible mouthpiece, a thin tube, and a smartphone-sized, silent, battery-powered control console to provide gentle oral negative pressure during sleep, comfortably maintaining an open airway while allowing normal breathing through the nose.
Founded Year
2017
Unified Business No.
55102608
Status
Active
Number of Employees
0
Total Paid-in
Capital
0 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
iNAP Sleep is a clinically focused medical technology company specializing in solutions for sleep-disordered breathing. Working closely with Somnics and multiple sleep medicine centers, the company advances next-generation intraoral negative airway pressure (iNAP) therapy. By combining AI predictive models with personalized treatment optimization technologies, iNAP Sleep improves both treatment success rates and patient adherence for individuals with obstructive sleep apnea (OSA). The company's mission is to provide a more comfortable, effective, and scalable alternative for patients who cannot tolerate traditional CPAP therapy while accelerating the global adoption of innovative sleep healthcare technologies.
